The Cost-Effectiveness of Selective Internal Radiation Therapies Compared with Sorafenib for Treating Advanced Unresectable Hepatocellular Carcinoma in the United Kingdom

To assess the cost-effectiveness of selective internal radiation therapy (SIRT) compared with sorafenib for the treatment of patients with advanced hepatocellular carcinoma in the United Kingdom, including a selected subgroup of patients who have been identified as benefiting from treatment with SIRT.

Source: Value in Health - December 16, 2021 Category: International Medicine & Public Health Authors: Lindsay Claxton, Matthew Walton, Sahar Sharif-Hurst, Ros Wade, Alison Eastwood, Robert Hodgson Tags: Economic Evaluation Source Type: research